SG11202004725PA - Protein purification and virus inactivation with alkyl glycosides - Google Patents

Protein purification and virus inactivation with alkyl glycosides

Info

Publication number
SG11202004725PA
SG11202004725PA SG11202004725PA SG11202004725PA SG11202004725PA SG 11202004725P A SG11202004725P A SG 11202004725PA SG 11202004725P A SG11202004725P A SG 11202004725PA SG 11202004725P A SG11202004725P A SG 11202004725PA SG 11202004725P A SG11202004725P A SG 11202004725PA
Authority
SG
Singapore
Prior art keywords
protein purification
virus inactivation
alkyl glycosides
glycosides
alkyl
Prior art date
Application number
SG11202004725PA
Other languages
English (en)
Inventor
Tobias Brandt
Hubert Metzner
Carsten Horn
Thomas Nowak
Original Assignee
CSL Behring Lengnau AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Behring Lengnau AG filed Critical CSL Behring Lengnau AG
Publication of SG11202004725PA publication Critical patent/SG11202004725PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/21—Pharmaceuticals, e.g. medicaments, artificial body parts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SG11202004725PA 2017-12-19 2018-12-19 Protein purification and virus inactivation with alkyl glycosides SG11202004725PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17208630 2017-12-19
PCT/EP2018/085735 WO2019121846A1 (en) 2017-12-19 2018-12-19 Protein purification and virus inactivation with alkyl glycosides

Publications (1)

Publication Number Publication Date
SG11202004725PA true SG11202004725PA (en) 2020-07-29

Family

ID=60888188

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202004725PA SG11202004725PA (en) 2017-12-19 2018-12-19 Protein purification and virus inactivation with alkyl glycosides

Country Status (11)

Country Link
US (1) US11479578B2 (da)
EP (2) EP3728287B1 (da)
JP (1) JP7458980B2 (da)
KR (1) KR20200100771A (da)
CN (1) CN111511756B (da)
AU (1) AU2018390797A1 (da)
BR (1) BR112020010760A2 (da)
CA (1) CA3085885A1 (da)
DK (1) DK3728287T3 (da)
SG (1) SG11202004725PA (da)
WO (1) WO2019121846A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023506494A (ja) * 2019-12-12 2023-02-16 イーライ リリー アンド カンパニー 環境適合性洗剤によるウイルス不活化のための方法
CN111110876A (zh) * 2020-01-20 2020-05-08 华兰生物工程重庆有限公司 一种特异性人免疫球蛋白病毒灭活工艺
BR112023018268A2 (pt) * 2021-03-09 2023-10-31 Japan Chem Res Método para produzir uma proteína de fusão
WO2023115027A2 (en) * 2021-12-16 2023-06-22 Bristol-Myers Squibb Company Detergent for viral inactivation
TW202403043A (zh) 2022-03-18 2024-01-16 美商健臻公司 重組人類酸性鞘磷脂酶醫藥組合物及方法
CN117866038B (zh) * 2024-03-11 2024-05-28 北京百力格生物科技有限公司 纯化含有宿主核酸的带亲和标签的酸性蛋白的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5759855A (en) 1988-09-14 1998-06-02 La Jolla Cancer Research Foundation Methods for modifying the binding activity of cell adhesion receptors
EP0531639B1 (en) * 1991-07-18 1999-09-01 F. Hoffmann-La Roche Ag Tocopherol cyclase
CN1103603C (zh) * 1993-08-06 2003-03-26 康诺特实验室有限公司 灭活的呼吸合胞体病毒疫苗
DE19528221C2 (de) * 1995-08-01 1998-10-22 Blutspendedienst Der Drk Lande Verfahren zur Herstellung eines virussicheren, therapeutischen Präparates aus Humanplasma
AU1583397A (en) 1996-01-30 1997-08-22 Brigham And Women's Hospital Antibodies for modulating cd47-mediated neutrophil transmigration
AU3514997A (en) 1996-07-12 1998-02-09 Schering Corporation Mammalian tnf-alpha convertases
AT405939B (de) * 1997-02-24 1999-12-27 Immuno Ag Verfahren zur inaktivierung von lipidumhüllten viren
AU2008200700C1 (en) * 1997-04-15 2013-04-04 Daiichi Sankyo Co., Ltd Novel Protein and Process for Producing The Same
US6610316B2 (en) * 1997-05-30 2003-08-26 Shanbrom Technologies, Llc Disinfection by particle-bound and insolubilized detergents
SE9904803D0 (sv) 1999-12-27 1999-12-27 Amersham Pharm Biotech Ab Method for the isolation of hydrophobic proteins
EP1578443B1 (en) * 2002-11-20 2011-01-12 Bestewil Holding B.V. Compositions comprising antigen-complexes, method for making same as well as methods of using the antigen-complexes for vaccination
US20100216161A1 (en) 2009-02-26 2010-08-26 Vertex Pharmaceuticals Incorporated Method for identifying protease inhibitors
AU2015252110A1 (en) * 2009-12-18 2015-11-26 Csl Limited Method of purifying polypeptides
AU2010202125B1 (en) * 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
AU2015204304B2 (en) * 2010-12-15 2016-04-07 Takeda Pharmaceutical Company Limited Viral Inactivation Using Improved Solvent-Detergent Method
EP2734619B1 (en) 2011-07-20 2017-09-06 BGP Products B.V. Process for producing orthomyxoviral antigen and vaccines
CN103214566A (zh) * 2013-03-30 2013-07-24 福州新北生化工业有限公司 一种g因子的分离纯化方法
HUE065394T2 (hu) * 2013-11-15 2024-05-28 Hoffmann La Roche Vírusok inaktiválására szolgáló eljárások környezetbarát detergensek alkalmazásával
SG11201708755WA (en) 2015-05-22 2017-12-28 Csl Behring Recombinant Facility Ag Truncated von willebrand factor polypeptides for treating hemophilia
JP2020529845A (ja) 2017-08-01 2020-10-15 アンカサ リジェネレイティブ セラピューティクス，インク． Ｗｎｔ組成物および無血清培養条件からの処理の方法

Also Published As

Publication number Publication date
JP7458980B2 (ja) 2024-04-01
BR112020010760A2 (pt) 2020-11-17
DK3728287T3 (da) 2024-06-10
WO2019121846A1 (en) 2019-06-27
CN111511756A (zh) 2020-08-07
EP4368210A2 (en) 2024-05-15
EP4368210A3 (en) 2024-07-24
JP2021506875A (ja) 2021-02-22
US20200317727A1 (en) 2020-10-08
KR20200100771A (ko) 2020-08-26
AU2018390797A1 (en) 2020-07-02
EP3728287A1 (en) 2020-10-28
EP3728287B1 (en) 2024-04-10
CN111511756B (zh) 2023-11-03
US11479578B2 (en) 2022-10-25
CA3085885A1 (en) 2019-06-27

Similar Documents

Publication Publication Date Title
IL273432A (en) Protein compounds and their uses
SG11202004725PA (en) Protein purification and virus inactivation with alkyl glycosides
ZA201900278B (en) Variant adeno-associated viruses and methods of using
IL267949A (en) A modified virus
IL268346A (en) Targeted chimeric proteins and their uses
EP3277819A4 (en) Adeno-associated virus variants and methods of use thereof
IL275533A (en) Adeno-associated virus purification methods
HK1231402A1 (zh) 治療 型肝炎和 型肝炎病毒感染的方法
EP3309251A4 (en) VIRAL VECTOR OF PARAINFLUENZA TYPE 2 HUMAN AND VACCINE
EP3284344A4 (en) Purification device and aquarium comprising same
EP3518947C0 (en) OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
GB201711481D0 (en) Protein purification
IL267639A (en) Oncolytic viruses and therapeutic molecules
HK1253377A1 (zh) 可編程的溶瘤病毒疫苗系統及其應用
HK1253557A1 (zh) 純化和/或病毒滅活的方法
HK1252343A1 (zh) 用於治療病毒感染的組合物和方法
EP3166637A4 (en) Compositions and methods for treating dengue virus infection
ZA202002069B (en) Novel mek-inhibitor for the treatment of viral and bacterial infections
EP3268034A4 (en) Non-neuroinvasive viruses and uses thereof
EP3569687A4 (en) VIRUS INACTIVATION KIT AND VIRUS INACTIVATION DEVICE
IL273229A (en) Methods for inactivating viruses using N-methylglucamide and its history
GB201808500D0 (en) Virus and virus use
GB201706600D0 (en) Virus preparations
GB201617487D0 (en) Reducing viral infection and/or viral reactivation during immunotherapy
GB201520957D0 (en) Reducing viral infection and/or viral reactivation during immunotherapy